Citigroup Maintains Neutral on Merck & Co, Raises Price Target to $145

Benzinga · 6d ago
Citigroup analyst Geoff Meacham maintains Merck & Co (NYSE:MRK) with a Neutral and raises the price target from $125 to $145.